FDA Inspection
Novartis Pharma Stein AGNovartis Pharma Stein AG – FDA Inspection, Jun 22, 2012
Record Details
This FDA Inspection record concerns Novartis Pharma Stein AG, with an inspection on June 22, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Novartis Pharma Stein AG
- Inspection Date
- June 22, 2012
- Product Type
- Drugs
View Company Profile
ID · 8ac5186e-490b-4203-92f2-5088421c6033
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 791807
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Novartis Pharma Stein AG
10| Date | Classification | Office | Project area |
|---|---|---|---|
| November 20, 2023 | Not classified | Office of Inspections and Investigations | |
| December 6, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 4, 2018 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| May 9, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 16, 2015 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
Other documents for Novartis Pharma Stein AG
- FDA Inspection 1230809 - 2023-11-20
- FDA Inspection 1192104 - 2022-12-06
- FDA Inspection 1073408 - 2018-12-04
- FDA Inspection 1015468 - 2017-05-09
- FDA Inspection 947993 - 2015-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.